Tradeweb to Buy Bond Platform Trumid for $1.97 Billion
Tradeweb Trumid deal: Tradeweb will buy bond-trading platform Trumid for about $1.97 billion, mostly in cash, with closing targeted in H1 2027.

Tradeweb Markets has agreed to buy electronic bond-trading platform Trumid Holdings for about $1.97 billion, the Nasdaq-listed company said in a statement on 19 October. The Tradeweb Trumid deal will expand Tradeweb’s corporate credit business, will be paid for mainly in cash and is expected to be completed in the first half of 2027.
Tradeweb Trumid deal: price and terms
The headline figure consists of $1.75 billion for the business and about $220 million for tax assets, valued at net present value using a 7% discount rate. The price is subject to customary adjustments.
Tradeweb will pay approximately $1.89 billion in cash, funded primarily from cash on hand, along with $82 million in equity. The boards of both companies unanimously approved the transaction, which remains subject to regulatory approvals and other customary closing conditions.
Tradeweb expects the acquisition to be accretive to adjusted earnings per share in the first full year after closing, the company said in its announcement. It expects the benefit to increase each year as expense synergies are realised, but it did not give a figure for those savings.
Morgan Stanley is acting as financial adviser to Tradeweb, and Goldman Sachs is advising Trumid. Fried Frank and Simpson Thacher are legal counsel to Tradeweb, while Latham & Watkins is advising Trumid.
What Trumid adds to electronic bond trading
Trumid operates a fixed-income electronic trading platform for US dollar-denominated credit, covering investment-grade, high-yield, distressed and emerging-market debt. It describes itself as a financial technology company that offers multiple trading protocols on one platform.
As reported by Securities.io, Trumid’s protocols will be made available on Tradeweb’s AllTrade platform, which will allow Tradeweb to move into grey-market and new-issue bond trading. Trumid has gained popularity with hedge funds and systematic traders, who tend to trade credit actively.
Billy Hult, CEO of Tradeweb, described the deal as “an important step forward in our ambition to make credit markets more efficient.” Mike Sobel, Co-CEO and President of Trumid, said the combined teams would build on what they had created and “accelerate innovation.”
Founded in 1996, Tradeweb runs electronic marketplaces for rates, credit, equities and money markets. It has more than 3,000 clients across more than 85 countries and averaged more than $3.0 trillion in notional value traded per day over the past four fiscal quarters, according to the company.
Why the Tradeweb acquisition matters for Wall Street
Corporate bond trading has taken longer than equities to move onto electronic screens. As more investors trade credit electronically, platforms will continue to compete for market share, and buying Trumid gives Tradeweb a larger share of business with active credit traders.
The deal also comes at a time when bond markets have been under pressure. With the US 10-year Treasury yield at around 5.1% on 19 October, high volatility can create demand for efficient execution platforms. Our earlier report explains why the US 10-year yield hit its highest level since 2007.
Tradeweb released the announcement after the market close on 19 October, a session in which the Nasdaq rose 1.1% and the S&P 500 gained 0.4% as technology stocks rebounded, according to TheStreet. No information was given on Trumid’s revenue, volumes or number of clients, so investors will have to wait to see what it adds to Tradeweb’s business.
For business leaders and investors, the Tradeweb Trumid deal shows that market-infrastructure companies are prepared to commit large sums of cash to gain scale in credit trading. With most of the price paid in cash, Tradeweb will issue only a small amount of stock.
Tradeweb will hold an investor call on 20 October at 8:30 am EDT to discuss the deal. It is due to announce third-quarter results on 29 October, when analysts may seek more detail on Trumid’s revenue and the expected cost synergies, neither of which was disclosed in the announcement. The deal still needs regulatory approval.







